Olalekan Oluwole

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Kite
    Topic:
    Advisory Board
    Date added:
    06/26/2023
    Date updated:
    06/26/2023
    Relationship end date:
    12/31/2023
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Gilead
    Topic:
    Consultant
    Date added:
    06/26/2023
    Date updated:
    06/26/2023
    Relationship end date:
    12/31/2023
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Abbvie
    Topic:
    Consultant
    Date added:
    06/26/2023
    Date updated:
    06/26/2023
    Relationship end date:
    06/30/2023
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Epizyme
    Topic:
    Consultant
    Date added:
    06/26/2023
    Date updated:
    06/26/2023
    Relationship end date:
    06/30/2023
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    ADC
    Topic:
    Consultant
    Date added:
    06/26/2023
    Date updated:
    06/26/2023
    Relationship end date:
    06/30/2023
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Nektar
    Topic:
    Consultant
    Date added:
    06/26/2023
    Date updated:
    06/26/2023
    Relationship end date:
    06/30/2023
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Caribou
    Topic:
    Consultant
    Date added:
    06/26/2023
    Date updated:
    06/26/2023
    Relationship end date:
    12/31/2023
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Cargo
    Topic:
    Consultant
    Date added:
    06/26/2023
    Date updated:
    06/26/2023
    Relationship end date:
    12/31/2023
Return to Seattle Cellular Therapy Summit: Patient-Centered Approach to Improve Outcomes